Abstract
In the introduction to our article (Pediatrics, 34:795, 1964) it is clearly stated that one inoculation of live measles vaccine is the immunization of choice for infants over 9 months of age. This regimen has obvious advantages over the combined inactivated-live measles vaccination procedures which entail multiple inoculations. On the other hand, live vaccine is not consistently immunogenic for younger infants because of the potential suppressive effect of residual passive antibody.
Passively acquired measles antibody may disappear as early as 3 months or as late as 11 months.
- Copyright © 1965 by the American Academy of Pediatrics
Individual Login
Log in
You will be redirected to aap.org to login or to create your account.
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.